No Detail Found!

Variations and Clinical Implications of Serum Gal-3 and IL-6 in Heart Failure Individuals Complicated with Renal Impairment

Author(s)
Jianlong Li Department of Cardiology, The Affiliated Hospital of Hebei University,Baoding, Hebei,China
Haiming Li Department of Cardiology, The Affiliated Hospital of Hebei University,Baoding, Hebei,China
Yichao Zhang Department of Cardiology, The Affiliated Hospital of Hebei University,Baoding, Hebei,China
Xing Fan Department of Nephrology, The Affiliated Hospital of Hebei University, Baoding, Hebei, China; Key Laboratory of Bone Metabolism and Physiology in Chronic Kidney Disease of Hebei Province, Baoding, Hebei, China
Qian Wang Department of Nephrology, The Affiliated Hospital of Hebei University, Baoding, Hebei, China; Key Laboratory of Bone Metabolism and Physiology in Chronic Kidney Disease of Hebei Province, Baoding, Hebei, China
Zhe Li Department of Nephrology, The Affiliated Hospital of Hebei University, Baoding, Hebei, China; Key Laboratory of Bone Metabolism and Physiology in Chronic Kidney Disease of Hebei Province, Baoding, Hebei, China
Abstract
Objective: To investigate the variations and clinical implications of serum Gal-3 and IL-6 values in individuals with heart failure (HF) complicated with renal impairment. Study Design: Analytical study. Place and Duration of the Study: Department of Nephrology, The A liated Hospital of Hebei University, Baoding, Hebei, China, from May 2022 to 2023. Methodology: A total of 80 HF individuals who were treated in the Department of Nephrology, The A liated Hospital of Hebei University, Baoding, Hebei, China, from May 2022 to 2023, were classi ed into the normal renal function band (n = 40) and the renal impairment band (n = 40) according to glomerular ltration rate (eGFR). The serum galactose-3 (Gal-3) and interleukin-6 (IL-6) values and their correlation with renal impairment were compared between the two bands, along with an analysis of the sensitivity and speci city of Gal-3 and IL-6 using receiver operating characteristic (ROC) curves. Results: There were higher Gal-3 and IL-6 values in the renal impairment band, in contrast to the normal renal function band (p <0.05). Spearman s correlation analysis indicated a signi cant association between Gal-3 and IL-6 values in HF individuals and renal impairment (p <0.05). The AUC values of Gal-3 and IL-6 in predicting renal impairment in HF individuals were <0.914 and <0.717, respectively; the speci city of Gal-3 and IL-6 in predicting renal impairment was 70.00% and 62.50%, respectively, the sensitivity was 97.50% and 80.00%, respectively. Conclusion: HF individuals complicated with renal impairment have increased serum Gal-3 and IL-6 values, both of which are signi cantly associated with renal impairment.
Publication Details
Page(s) 297-301
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 3, Year: 2025

Request the full text from PASTIC

Keywords
Heart failure, Renal impairment, Interleukin-6 protein, Galactose lectin-3
References
Zaborska B,Frac MS,Smarz K,Paszkiet EP,Budaj A,Sitkiewicz D .2023 .The role of Galectin-3 in heart failure-The diagnostic, prognostic and therapeutic potential-where do we stand?. Int J Mol Sci, 10(17) : 13111.
Iacoviello M,Di Serio F,Rizzo C,Leone M,Grande D,Guida P .2019 .Association between high Gal-3 serum levels and worsening of renal function in chronic heart failure outpatients. Biomark Med, 13(9) : 707-13.
. .. , : .
Kotby AA,Youssef OI,Elmaraghy MO .2017 .Galectin-3 in children with chronic heart failure with normal and reduced ejection fraction: Relationship to disease severity. Pediatr Cardiol, 10(1) : 95-102.
. .Chinese society of cardiology of Chinese medical association; editorial board of Chinese Journal of Cardiology. [Guidelines for the diagnosis and management of chronic heart failure]. Zhonghua Xin Xue Guan Bing Za, 35(12) : 1076-95.
Savarese G,Becher PM,Lund LH,Seferovic P,Rosano GMC,Coats AJS .2023 .Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc Res, 10(17) : 3272-87.
Han R,Li K,Li L,Zhang L,Zheng H .2019 .Expression of microRNA-214 and galectin-3 in peripheral blood of patients with chronic heart failure and its clinical signi canceE. xp Ther Med, 8318(2) : 1322-8.
Costanzo MR .2019 .The cardiorenal syndrome in heart failure. Heart Fail Clin, 08(1) : 81-97.
Luo BJ,Kong MH. .2019 .Clinical value of plasma growth di erentiation factor15, galectin3 and copeptin in diagnosis of cardiorenal syndrome. Hebei Med J, 08(8) : 7386-6.
Plonka J,Olejnik A,Klus A,Dryja EG,Wylegala NW,Rzepiela L .2022 .Protective role of protein Klotho biomarker in acute heart failure. Euro Heart J Acute Cardio Care, 10 : 157.
Watanabe S,Lei M,Nakagawa E,Takeshita E,Inamori KI,Shishido F .2023 .Neurological insights on two siblings with GM3 synthase de ciency due to novel compound heterozygous ST3GAL5 variants. Brain Dev, 01(5) : 270-7.
Gaborit FS,Bosselmann H,Kistorp C,Iversen K,Kumler T .2016 .Galectin 3: Association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure. BMC Cardiovasc Disord, 10 : 117.
Bailon MM,Babkwoski MC .2020 .Monitoring renal damage in acute heart failure. Do we need a more global and comprehensive approach?. Rev Clin Esp, 02(9) : 576-7.
Brankovic M,Akkerhuis KM,Hoorn EJ,van Boven N,van den Berge JC,Constantinescu A .2020 .Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study. Clin Cardiol, 10(6) : 630-8.
Verbrugge FH,Guazzi M,Testani JM,Borlaug BA JM .2020 .Altered hemodynamics and end-organ damage in heart failure: Impact on the lung and kidneyC. irculation, 10(10) : 998-1012.
Tian F,Chen LP,Yuan G,Zhang AM,Jiang Y,LI S Y .2020 .Di erences of TNF-±, IL-6 and Gal-3 in lobar pneumonia and bronchial pneumonia caused by mycoplasma pneumoniae. Technol Health Care, 10(6) : 711-9.
Z. .2019 .Changes in expression of serum chemokine CXCL13 and IL-6 after hip replacement, and the relationship with lower limb vein thrombus. Exp Ther Med, 8365(3) : 2113-8.
Zhang Q,Dong G,Wang F,Ding W.,VEGF W. .2020 .and TSGF levels and prognosis in patients with osteosarcoma before and after treatment. J Cancer Res Ther, 11(2) : 20-42.
Baccouche BM,Mahmoud MA,Nief C,Patel K,Horowitz BN .2023 .Galectin-3 is associated with heart failure incidence: A Meta-Analysis. Curr Cardiol Rev, 10(3) : e17112.
Perez PC,Gonzalez-Juanatey JR,Nuche J,Blanco LM,Serrano I,Selles MM .2022 .Renal function impact in the prognostic value of Galectin-3 in acute heart failure. Front Cardiovasc Med, 861651 : 861651.
Liu GW,Zeng JE,Li LF .2022 .Correlation analysis of serum IGF-1 and IL-6 and urinary albumin/creatinine ratio in patients with type 2 diabetic kidney disease. Front Endocrinol (Lausanne), 1082492 : 1082492.
Yin C,Cheng C,Wang J,Zhang L,Purrunsing Y,Yang G .2020 .The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease. Clin Nephrol, 10(2) : 65-76.
He L,Qing F,Li M,Lan D M .2021 .Gal-3 in patients with thyroid cancer. Gland Surg, 10(3) : 1085-92.
0

Citations

0

Downloads

97

Views